Psychiatric Medication, Practically

Your First Week on Vyvanse: What It Should and Shouldn't Feel Like

Save

On target, Vyvanse's first week feels like quiet, unremarkable focus with a gradual morning ramp -- not euphoria or wire. Expect appetite suppression through midday and a felt wear-off by late afternoon. Racing heart, edginess, or a hard evening mood drop are report-to-prescriber signals, not features to endure.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What does "working correctly" actually feel like?

The genuine surprise for most adults is how subtle it is. Lisdexamfetamine is a prodrug -- your body converts it gradually -- so the onset is a slow ramp over the first hour or two, not a switch flipping 1. On a well-matched day, what you notice is mostly absence: less friction starting tasks, fewer open tabs in your head, time moving at a workable pace. People often report their first clue was finishing something boring without negotiating with themselves. Feeling chatty, euphoric, or powerful is not the target state; stimulant medication at the right fit produces function, not sensation 1. If the main thing you feel is the drug itself, that observation belongs in your follow-up notes.

Why do afternoons feel like something switched off?

Vyvanse's design gives it a long, smooth arc -- commonly described as ten to twelve hours from a morning start -- but the tail end is real, and late afternoon is when many people feel focus friction return 1. A distinct wear-off is normal and worth logging: what time it lands, how sharp it feels, and what it costs your evening. A gentle fade is expected; a hard crash -- sudden irritability, heaviness, or a mood drop -- is a report-worthy pattern, not a personal failing. The difference between ordinary wear-off and something worth flagging is unpacked in stimulant crash versus withdrawal. Your prescriber can only tune what you can describe, so specifics beat vibes.

What happens to appetite and sleep this week?

Appetite suppression is the most predictable passenger: hunger often goes quiet from mid-morning through afternoon and returns in the evening, which is why stimulants reduce appetite has become its own topic of management. Weight and eating patterns are things prescribers actively monitor on stimulants, so mention early if whole days are passing with little food 1. Sleep is the other watch item: a morning-anchored routine usually protects it, but trouble falling asleep in week one still happens while your system adjusts. Track both honestly -- appetite and sleep data are two of the first things a prescriber asks about at follow-up, and both have workable answers when raised early.

Which first-week signals mean call the prescriber?

A short list should not be waited out: a racing or pounding heart, chest pain, or breathlessness; feeling wired, edgy, or unable to stop moving; a severe evening mood cliff; new suspicion or seeing things that are not there; or any thought of self-harm. Federal guidance flags cardiac symptoms and new psychiatric symptoms as stimulant warnings deserving prompt medical attention rather than adjustment-window patience 1. Milder versions of edginess or anxiety are still worth reporting at follow-up -- stimulants can amplify anxiety in some people, and fit matters 1. One more first-week reality: Schedule II logistics make refills unforgiving, so knowing how early a stimulant can be refilled prevents an involuntary gap later.

When a clinician helps

Week one ends best with a written record and a scheduled conversation. Prescribers starting adults on a first stimulant typically want early follow-up -- often within the first month -- to review focus, appetite, sleep, mood, and blood pressure, and your daily notes make that visit count 1. Book it now if it is not on the calendar. Describing both what improved and what it cost is the whole job; research on treatment preference finds that plans people genuinely accept are the ones that last 2. If you have lost touch with the prescriber who started this, free referral lines like SAMHSA's National Helpline can reconnect you with care 3. Gale can also help you find prescribers who treat the first month as a dialogue, which is what good stimulant care looks like.

Common questions

Mostly no -- the onset is a gradual ramp over an hour or two, and the target state is quiet function rather than a felt buzz. A strong "kick" sensation is worth mentioning to your prescriber.

No. A felt wear-off in late afternoon is expected with a long-acting morning stimulant. A harsh crash -- irritability, heaviness, mood drop -- is the version worth reporting.

Daytime appetite suppression is very common and usually manageable, but tell your prescriber early -- eating patterns and weight are things they monitor on stimulants, and timing meals around the medication's arc is a solvable problem.

It can raise flags -- racing heart, wire, mood cliffs -- but fit judgments belong to your prescriber with your notes in hand. One week is data collection, not a verdict.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Stimulant signals that need prompt attention

  • —Chest pain, fainting, or a racing, pounding heartbeat
  • —New paranoia, hearing or seeing things that are not there
  • —Agitation or feeling unable to stop moving
  • —New or worsening thoughts of self-harm

This article describes common first-week experiences with lisdexamfetamine; it is general education, not medical advice about your prescription. Report concerning symptoms to your prescriber promptly. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline), free and available 24/7.

References

  1. 1.National Institute of Mental Health (NIMH) (2024). Mental Health Medications. National Institute of Mental Health (NIMH). link ✓ssri-anti-anxiety-medsptsd-medicationdepression-treatmentdrinking-on-antidepressants
  2. 2.McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW (2013). Patient Preference for Psychological vs Pharmacologic Treatment of Psychiatric Disorders: A Meta-Analytic Review. The Journal of Clinical Psychiatry. doi:10.4088/JCP.12r07757 ✓treatment-preferencetherapy-vs-medicationshared-decision-making
  3. 3.Substance Abuse and Mental Health Services Administration (2025). National Helpline for Mental Health, Drug, Alcohol Issues. Substance Abuse and Mental Health Services Administration (SAMHSA). link ✓treatment-accesscrisis-supporthelp-seeking

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library